FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Claris Lifesciences Levofloxacin Injection in 5% Dextrose Recall

Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only, Manufact…

Claris Lifesciences Inc · North Brunswick, NJ

Risk level
Class II
Reported by FDA
Apr 5, 2017
Recall ID
D-0615-2017
Check your lot numberHow we source this data

Summary

Claris Lifesciences recalled Levofloxacin Injection in 5% Dextrose starting Mar 10, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0615-2017 on Apr 5, 2017. Reason: Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Product description

Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-048-24

Lot numbers, UPCs & expiration codes

Lot #: A060040, Exp. Dec 2017

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0615-2017
Classification
Class II
Status
Terminated
Recall initiated
Mar 10, 2017
FDA report date
Apr 5, 2017
Quantity
24,456 units (1019 cartons x 24 bags)
Recall type
Voluntary: Firm initiated
Recalling firm
Claris Lifesciences Inc

Original FDA data

Every field from FDA enforcement report D-0615-2017, exactly as published.

Show all FDA fields
City
North Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
76733
Address
1445 US Highway 130
Code information
Lot #: A060040, Exp. Dec 2017
Postal code
08902-3100
Report date
Apr 5, 2017
Product type
Drugs
Recall number
D-0615-2017
Classification
Class II
Recalling firm
Claris Lifesciences Inc
Product quantity
24,456 units (1019 cartons x 24 bags)
Termination date
Sep 18, 2020
Reason for recall
Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only, Manufactured for: Claris Lifesciences Inc. North Brunswick NJ, 08902, By: Claris Injectable Ltd. Gujarat, India, NDC 36000-048-24
Distribution pattern
Nationwide
Recall initiation date
Mar 10, 2017
Initial firm notification
Letter
Center classification date
Mar 24, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0615-2017, published Apr 5, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls